Drug Trial Radar · NCT06238622
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,666
Actual
Start
Sep 26, 2024
Primary completion
Apr 28, 2027
Study completion May 7, 2027
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Feb 2, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out how well people with pulmonary fibrosis tolerate long- term treatment with nerandomilast. The study also tests whether nerandomilast improves lung function and prolongs the time until symptoms get worse, participants need to go to the hospital, or die. Every participant takes nerandomilast as tablets for up to 1 year and 10 months. The participants may also continue their regular treatment for pulmonary fibrosis during the study. Participants visit their doctors regularly. During these visits, the doctors collect information on any health problems of the participants. Participants also regularly do lung function tests.
Conditions
- Idiopathic Pulmonary Fibrosis
- Progressive Pulmonary Fibrosis
Interventions
NerandomilastDrug
Nerandomilast
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of any adverse event over the course of the extension trial (yes/no) i.e. up until the follow-up/end of study visit planned at the latest at week 99Time frame: Up to 99 weeks and 3 days
Locations
375 sites in 44 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
University of Arizona
Tucson, Arizona
University of Southern California
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California Los Angeles
Los Angeles, California
University of California Davis
Sacramento, California
National Jewish Health
Denver, Colorado
Yale University School of Medicine
New Haven, Connecticut
Christiana Hospital
Newark, Delaware
Georgetown University
Washington D.C., District of Columbia
St. Francis Medical Institute
Clearwater, Florida
University of Florida
Gainesville, Florida
Clinical Research Specialists LLC - Kissimmee
Kissimmee, Florida
Advanced Pulmonary Research Institute
Loxahatchee Groves, Florida
Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead
Atlanta, Georgia
The Emory Clinic
Atlanta, Georgia
Northshore University Health System
Evanston, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Tulane Medical Center
New Orleans, Louisiana
Johns Hopkins Hospital
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
St. Elizabeth's Medical Center
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Corewell Health William Beaumont University Hospital
Royal Oak, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic, Rochester
Rochester, Minnesota
The Lung Research Center, LLC
Chesterfield, Missouri
Creighton University
Omaha, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska
Renown Regional Medical Center
Reno, Nevada
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Northern Westchester Hospital
Mount Kisco, New York
New York Presbyterian Hospital -Columbia University
New York, New York
NewYork-Presbyterian/Weill Cornell Medical Center
New York, New York
Duke University Medical Center
Durham, North Carolina
Southeastern Research Center-Winston Salem-69289
Winston-Salem, North Carolina
University of Cincinnati
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Showing 40 of 375 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.